Cytek Biosciences Inc (NAS:CTKB)
$ 5.6 0.03 (0.54%) Market Cap: 735.13 Mil Enterprise Value: 479.43 Mil PE Ratio: 0 PB Ratio: 1.87 GF Score: 60/100

Cytek Biosciences Inc at Piper Sandler Healthcare Conference Transcript

Dec 01, 2022 / 01:30PM GMT
Release Date Price: $13.03 (+1.09%)
Unidentified Analyst

Thank you, everybody. Thank you for joining us. I'm here with Cytek.

Questions & Answers

Unidentified Analyst

We're just going to go ahead, if you don't mind. I'm just going to jump in. Wenbin, this one's for you. It's not for Patrik, because it's about having a telecommunications background. How you came up with the concept of Cytek, despite, yes, with the telecommunications background?

Wenbin Jiang
Cytek Biosciences, Inc. - CEO & Chairman of the Board

Thank you for your question. Back in 2014, I was -- at that time, I was still in a different industry, telecom industry. Talking to, today, my Co-Founder of the company, about what we can do for the healthcare industry. And we started to discuss about the overall market needs. And at that time, we realized there's a lot of potential with regarding to high parameter cell analysis. But the available tools at that time was scarce and also difficult to use. And we feel then we started to have some conversation. And from my background, of course, in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot